Emotional and cognitive disorders are common in Parkinson's disease, but are frequently overlooked or undertreated. This book provides a comprehensive account of these aspects of Parkinson's disease, based on the neurological and psychiatric assessment of hundreds of patients by the authors. It also offers a thorough survey of the published literature on the topic. Readers will find a complete and helpful overview of the clinical features and treatment of Parkinson's disease, followed by discussion of associated depressive disorders, anxiety, phobias, apathy, hallucinations, delusions and sleep disorders. Specific cognitive deficits are also discussed, and the mechanisms for these disorders explored. The book also addresses the psychiatric and cognitive side effects of anti-parkinsonian medications and surgical treatments. Offering sufficient scientific detail for the specialist in neurology and psychiatry, the clear practical guidelines, case studies and rating scales will meet the needs of all clinicians working with Parkinson's disease patients.

‘The layout and style is accessible and clear and the addition of clinical vignettes makes for an engaging and educational read … There is sufficient scientific detail for the specialist, but with clear practical guidelines, case studies, and rating scales it will meet the needs of all those working with people who have PD.’

Source: The Lancet

‘This book provides a wealth of information in a succinct and accessible format … This book will be valued by both clinicians and investigators in the field.’

Daniel B. Hier - University of Illinois, Chicago College of Medicine

‘… an excellent text that should be helpful not only to old-age psychiatrists such as me but also to general practitioners, community health nurses and neurologists … Starkstein and Merello have provided a much needed text and I strongly recommend it.’

Adrian Treloar Source: Journal of the Royal Society of Medicine

'This book offers a … comprehensive account of the emotional problems that are encountered in Parkinson's disease: cognitive deficits, depression, anxiety, neuropsychological and psychiatric side effects of antiparkinsonian medications.'

Source: Psychotherapy and Psychosomatics